“…The findings of the study shed light on the impact of the pandemic-related restrictions on the management of T2DM, including the influence of stress, anxiety, and lifestyle changes on glycemic control. 1 The study's observation that people with T2DM treated with oral antidiabetics demonstrated better glycemic control compared to those treated with insulin therapy is particularly noteworthy. Additionally, the study highlights the challenges faced by T2DM patients in maintaining a balanced lifestyle and managing their disease during the pandemic.…”